AOUI Verona - Ospedale Borgo Roma

Verona 37134

0 studies enrolling now · 3 studies all time

What they study most

Advanced Cholangiocarcinoma, Cholangiocarcinoma, FGFR2 Fusions, FGFR2 Gene Rearrangements, Gene Rearrangement

Studies at this site

• Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement — Recruiting now
• Study of Tinengotinib VS. Physician's Choice a Treatment of Subjects With FGFR-altered in Cholangiocarcinoma — Running, not enrolling
• Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements — Stopped early